Tax Season is Here! Save 15% on H&R Block Online
iconAll times are GMT -4. The time now is 02:28 AM. | Search:

» StockRants Stock Forum » Public Stock Forums » US Penny Stock Picks » Strong Buy: IGXT (MC $32 M) 2 FDA approvals coming + 2 new NDA Filings in 4Q = 10 +Bagger



Reply
 
Thread Tools Search this Thread
Old 08-19-2016, 02:52 PM   Nav to Top  #11
Biohero
Senior Trader
 
Biohero's Avatar
 
Join Date: Jan 2012
Location: Frankfurt
Posts: 239
Favorites: Aapl celg onxx
Rep Power: 104
Reputation: 36
Biohero is on a distinguished road
Thread Starter
Default

Stock looks fantastic on all fronts, there is a good chance to break the $1 Mark next Week ..GL


IGXT | Barchart Opinion for Intelgenx Technologs
Biohero is offline   Rate this post Yes | No Reply With Quote
Old 08-22-2016, 09:10 AM   Nav to Top  #12
Biohero
Senior Trader
 
Biohero's Avatar
 
Join Date: Jan 2012
Location: Frankfurt
Posts: 239
Favorites: Aapl celg onxx
Rep Power: 104
Reputation: 36
Biohero is on a distinguished road
Thread Starter
Default

GREAT NEWS OUT .. and stock is stiill terrible underpriced at a market cap of laughable $52 Million .GL

http://www.intelgenx.com/investors/p...n/default.aspx

IntelGenx Announces Successful Clinical Study for Montelukast for the Treatment of Degenerative Diseases of the Brain
August 22, 2016

"We are very pleased by the results of the study which confirmed that our Montelukast VersaFilm™ significantly improves the bioavailability of the drug when given as an oral film product. The study demonstrates that the VersaFilm™ technology is an effective delivery system for CNS applications," said Dr. Horst G. Zerbe, President and CEO of IntelGenx. "Montelukast is an important drug repurposing opportunity that the company has in its product pipeline which could potentially become a multi-billion-dollar product in the large and underserved market for degenerative diseases of the brain."
Biohero is offline   Rate this post Yes | No Reply With Quote
Old 08-23-2016, 10:07 AM   Nav to Top  #13
Biohero
Senior Trader
 
Biohero's Avatar
 
Join Date: Jan 2012
Location: Frankfurt
Posts: 239
Favorites: Aapl celg onxx
Rep Power: 104
Reputation: 36
Biohero is on a distinguished road
Thread Starter
Default

IGXT is in discussions with 33 Pharmaceutical Companies maybe some of them wants to takeover IGXT because IGXT is a gift here with a Market Cap of ridiculous $50 Million , its much more attractive to takeover IGXT than to pay royalties at this Levels .


"With respect to other BD activities, we're clearly focusing right now in the business development area on bringing in new deals. For example at the recent BIO Conference, we met with 50 different pharmaceutical companies to discuss partnering opportunities, and we're currently in discussions with eight companies that are interested in RIZAPORT licenses, 17 companies that are interested in our Tadalafil product, three companies are interested in our schizophrenia drug, and five companies have expressed interest in a deal on Forfivo outside of the US."
Biohero is offline   Rate this post Yes | No Reply With Quote
Old 08-26-2016, 09:40 AM   Nav to Top  #14
Biohero
Senior Trader
 
Biohero's Avatar
 
Join Date: Jan 2012
Location: Frankfurt
Posts: 239
Favorites: Aapl celg onxx
Rep Power: 104
Reputation: 36
Biohero is on a distinguished road
Thread Starter
Default

New Presenation out shows that there is already strong interest in Montelukast after positive results (page 13) .We have a MEGA Pipeline ,a lot of Cash for 2 Years and many Drugs close to NDA Submissions all this for a brutal terrible low valuation of $50 Million .IGXT is definitely a MUST HAVE at these levels and patience will payoff big time here thats for sure .

http://s2.q4cdn.com/790425727/files/...esentation.pdf
Biohero is offline   Rate this post Yes | No Reply With Quote
Old 08-31-2016, 09:55 AM   Nav to Top  #15
Biohero
Senior Trader
 
Biohero's Avatar
 
Join Date: Jan 2012
Location: Frankfurt
Posts: 239
Favorites: Aapl celg onxx
Rep Power: 104
Reputation: 36
Biohero is on a distinguished road
Thread Starter
Default

RALLLYYYYYYYYYYYYYYYYYYYYYYYYYYYYYY i love this stock
Biohero is offline   Rate this post Yes | No Reply With Quote
Old 06-02-2017, 10:11 AM   Nav to Top  #16
Biohero
Senior Trader
 
Biohero's Avatar
 
Join Date: Jan 2012
Location: Frankfurt
Posts: 239
Favorites: Aapl celg onxx
Rep Power: 104
Reputation: 36
Biohero is on a distinguished road
Thread Starter
Default

Im back in this one because a lot of good news is on the way see below . Tadalafil a thin-film version of the blockbuster drug Cialis could enter the market up to2-3 years before the generics which is MEGA News for Intelgenx .US-NDA submission for Tadalafil expected 4-8 weeks and there is strong partner interest for the drug term sheet already received .I think now is a very good entry point .GL

Market Cap :$46 Million
Cash: Untill 2021+ (including convertible debt)
Price: 0.72

NDA submission for tadalafil in June or July
NDA resubmission for Rizaport in July or August
Partnership for Tadalafil in 2H 2017


400 Bad Request

IntelGenx previously confirmed the bioequivalence of Tadalafil to Eli Lilly’s Cialis, which had sales of $1.5-billion in 2016 but faces generic competition in 2020. IntelGenx has an exclusive license for oral films from Lilly for its dosing patent, which would allow Tadalafil to enter the ED market in the U.S. free from patent litigation from Lilly. Dr. Matzen explains that Tadalafil, which offers a discrete dosing alternative, could enter the market in 2018, with up to three years of market exclusivity before Cialis is hit with generic competition.


transcript may 2017
http://s2.q4cdn.com/790425727/files/...s-18899915.pdf


The trial with the ANDA applicants that submitted applications for generic copies, is scheduled for July. Some of the ANDA applicants have already settled with Lilly, settled in the sense that they have greed to launch their generic product only at the expiry of this third patent, the dosing patent that we obtained a license for. That means that we have a pretty good chance to enjoy an extended period of excessivity once we’ve launched our product. Several companies have expressed interest in licensing the product. Term sheets(phon)have been submitted and are currently being reviewed and the due-diligence process has commenced.
Biohero is offline   Rate this post Yes | No Reply With Quote
Old 06-08-2017, 09:36 AM   Nav to Top  #17
Biohero
Senior Trader
 
Biohero's Avatar
 
Join Date: Jan 2012
Location: Frankfurt
Posts: 239
Favorites: Aapl celg onxx
Rep Power: 104
Reputation: 36
Biohero is on a distinguished road
Thread Starter
Default

Good News and more to come

IntelGenx Announces Issuance of US Patent for Topical Oral Film Technology
June 08, 2017
IntelGenX Corp. - IntelGenx Announces Issuance of US Patent for Topical Oral Film Technology

IntelGenX on the way to take some of the $16bn thin films market
https://investorintel.com/sectors/bi...n-film-market/
Biohero is offline   Rate this post Yes | No Reply With Quote
Old 06-12-2017, 11:28 AM   Nav to Top  #18
Biohero
Senior Trader
 
Biohero's Avatar
 
Join Date: Jan 2012
Location: Frankfurt
Posts: 239
Favorites: Aapl celg onxx
Rep Power: 104
Reputation: 36
Biohero is on a distinguished road
Thread Starter
Default

Market Cap : $48 Million / Profitability expected in 2018 /very low burn-rate of $600-700K a Quarter / Cash untill 2021+ (including convertible debt) , if everything goes well then this stock could run to $10 even then it wouldnt be expensive = Very attractive and underpriced Pharma Play.

NDA submission for Tadalafil (erectile dysfunction) in June or July >> FDA approval in 1H 2018 (Peak Sales $120-150 Million)

NDA REsubmission for Rizaport(Migraine) in July or early August >> FDA approval 1Q 2018 (Peak Sales $50-60 Million)

Patent ruling regarding the Par Pharma Drug (opioid dependence) in June 2017 >> Market Launch expected in 1H 2018 (Peak Sales $70-80 Million)

Start Phase 2a for Montulukast (Alzheimer disease) in June >> Phase 2a Results in 4Q 2017 (BLOCKBUSTER Candidate)

MEGA Pipeline
http://s2.q4cdn.com/790425727/files/...-2017.xlsx.jpg

Presentation
http://s2.q4cdn.com/790425727/files/...-EN-June-5.pdf
Biohero is offline   Rate this post Yes | No Reply With Quote
Old 06-19-2017, 01:34 PM   Nav to Top  #19
Biohero
Senior Trader
 
Biohero's Avatar
 
Join Date: Jan 2012
Location: Frankfurt
Posts: 239
Favorites: Aapl celg onxx
Rep Power: 104
Reputation: 36
Biohero is on a distinguished road
Thread Starter
Default

nice move today looks like good news is on the way
Biohero is offline   Rate this post Yes | No Reply With Quote
Old 06-26-2017, 01:09 PM   Nav to Top  #20
Biohero
Senior Trader
 
Biohero's Avatar
 
Join Date: Jan 2012
Location: Frankfurt
Posts: 239
Favorites: Aapl celg onxx
Rep Power: 104
Reputation: 36
Biohero is on a distinguished road
Thread Starter
Default

Major breakout imminent ,stock is only a few cents from multiple year high away

https://stockcharts.com/c-sc/sc?s=ig...4726544&r=3658
Biohero is offline   Rate this post Yes | No Reply With Quote
Reply

Similar Threads
Thread Thread Starter Forum Replies Last Post
Strong Buy: IGXT (MC $27 M) PDUFA Date on February 3 // 10 Dugs in Late Stage = 10+ Bagger Biohero US Penny Stock Picks 0 11-05-2013 12:38 PM
Strong Buy: IGXT (Mcap $32 M) Submits NDA in March + 3x NDA filings in 1H13 Biohero US Penny Stock Picks 13 08-08-2013 06:48 AM
Strong Buy: IGXT (Mcap $31 M) 1x Drug launched + 2x NDA filings in 1Q13 + Profitable in 2013 Biohero US Penny Stock Picks 0 12-30-2012 07:57 PM
Strong Buy: IGXT (Mcap $29 M) 1x Drug launched + 2x NDA filings in 1Q13 + Profitable in 2013 Biohero US Penny Stock Picks 0 12-27-2012 07:34 AM
Strong Buy: 4x Approvals Coming (Mcap 54 M)Low float 4 M biotechmaster Canadian Stock Picks 0 01-17-2011 08:15 AM


Thread Tools Search this Thread
Search this Thread:

Advanced Search

Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts

BB code is On
Smilies are On
[IMG] code is On
HTML code is On